New Zealand markets open in 5 hours 31 minutes

Thermo Fisher Scientific Inc. (TMO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
531.52-4.25 (-0.79%)
As of 12:28PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 212.81B
Enterprise value 243.32B
Trailing P/E 28.33
Forward P/E 23.92
PEG ratio (5-yr expected) 3.83
Price/sales (ttm)5.24
Price/book (mrq)5.20
Enterprise value/revenue 5.92
Enterprise value/EBITDA 20.27

Trading information

Stock price history

Beta (5Y monthly) 0.83
52-week change 36.20%
S&P500 52-week change 3-11.08%
52-week high 3672.34
52-week low 3497.83
50-day moving average 3543.39
200-day moving average 3583.99

Share statistics

Avg vol (3-month) 31.44M
Avg vol (10-day) 31.26M
Shares outstanding 5391.46M
Implied shares outstanding 6N/A
Float 8390.63M
% held by insiders 10.38%
% held by institutions 190.81%
Shares short (30 May 2022) 43.04M
Short ratio (30 May 2022) 41.97
Short % of float (30 May 2022) 40.78%
Short % of shares outstanding (30 May 2022) 40.78%
Shares short (prior month 28 Apr 2022) 43.39M

Dividends & splits

Forward annual dividend rate 41.2
Forward annual dividend yield 40.23%
Trailing annual dividend rate 31.08
Trailing annual dividend yield 30.20%
5-year average dividend yield 40.24
Payout ratio 45.63%
Dividend date 314 Jul 2022
Ex-dividend date 413 Jun 2022
Last split factor 23:2
Last split date 305 Jun 1996

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)01 Apr 2022


Profit margin 18.49%
Operating margin (ttm)24.27%

Management effectiveness

Return on assets (ttm)7.86%
Return on equity (ttm)19.98%

Income statement

Revenue (ttm)41.12B
Revenue per share (ttm)104.51
Quarterly revenue growth (yoy)19.30%
Gross profit (ttm)19.64B
Net income avi to common (ttm)7.6B
Diluted EPS (ttm)19.19
Quarterly earnings growth (yoy)-5.20%

Balance sheet

Total cash (mrq)2.75B
Total cash per share (mrq)7.03
Total debt (mrq)33.26B
Total debt/equity (mrq)80.85
Current ratio (mrq)1.56
Book value per share (mrq)104.62

Cash flow statement

Operating cash flow (ttm)9.54B
Levered free cash flow (ttm)5.74B